Patent · US Active

Crystalline dapagliflozin hydrate

US9394328B2 · kind B2 · utility

4Cited by
7References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 28, 2012
Grant dateJul 19, 2016
Priority date—
Expiry dateNov 28, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D309/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A crystalline dapagliflozin hydrate and a process for obtaining the same is described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.